Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 3/20 | 0.53 |
| ▸ | ARG2 | P78540 | 2/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 11/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 11/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 11/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 10/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1359692 | 1.00 | ARG1 (0.53) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1359695 | 1.00 | ARG1 (0.53) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31106404 | 0.94 | ARG1 (0.47) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4204210 | 0.94 | ARG1 (0.47) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL17393104 | 0.92 | ARG1 (0.46) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11650757 | 0.84 | ARG1 (0.58) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4406496 | 0.84 | ARG1 (0.58) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL15922626 | 0.83 | ARG1 (0.41) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL15664945 | 0.81 | ARG2 (0.64) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3676543 | 0.81 | ARG1 (0.54) | ARG1ARG2SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120091999-A | 3-Pyrrolidine-indole dimers as serotonergic agents for the treatment of related disorders | 思维模式制药公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-119546591-A | Indoline derivatives as serotonergic agents for the treatment of related disorders | 思维模式制药公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-115380028-A | 3-pyrrolidine-indole derivatives as serotonergic hallucinogens for the treatment of CNS disorders | 明德赛特制药公司 | 2022-11-22 | — | — | CN | disclosed |